Jump Financial LLC Sells 81,867 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Jump Financial LLC lessened its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 96.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 3,189 shares of the medical device company’s stock after selling 81,867 shares during the period. Jump Financial LLC’s holdings in Cooper Companies were worth $293,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in COO. JPMorgan Chase & Co. raised its holdings in Cooper Companies by 1.5% during the fourth quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company’s stock worth $460,066,000 after buying an additional 74,501 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Cooper Companies by 2.3% in the 4th quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company’s stock worth $449,907,000 after acquiring an additional 109,907 shares during the last quarter. Victory Capital Management Inc. lifted its position in Cooper Companies by 14.6% in the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company’s stock valued at $415,985,000 after acquiring an additional 574,899 shares in the last quarter. Norges Bank bought a new position in Cooper Companies in the 4th quarter valued at about $217,906,000. Finally, FMR LLC boosted its stake in Cooper Companies by 97.6% during the 4th quarter. FMR LLC now owns 2,218,112 shares of the medical device company’s stock valued at $203,911,000 after purchasing an additional 1,095,805 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Performance

NASDAQ COO opened at $80.89 on Friday. The company has a market capitalization of $16.18 billion, a PE ratio of 41.48, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The Cooper Companies, Inc. has a 52-week low of $69.81 and a 52-week high of $112.38. The company has a 50-day simple moving average of $82.13 and a 200 day simple moving average of $92.68.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. On average, research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Upgrades and Downgrades

COO has been the topic of a number of recent research reports. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Friday, March 7th. JPMorgan Chase & Co. dropped their price objective on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Friday, March 7th. Stifel Nicolaus reduced their target price on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a research note on Friday, March 7th. Citigroup dropped their price target on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Friday, March 7th. Finally, BNP Paribas upgraded shares of Cooper Companies to a “hold” rating in a report on Thursday, March 13th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.